/PRNewswire/ The "Blood Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com s offering This report provides strategists,.
Search jobs 12-Mar-2021 Implementation of government regulations will boost the blood cancer drugs market, forecast to touch US$ 41 Bn by 2025 at a CAGR of 6%
Noida, Uttar Pradesh, India, March 12 2021 (Wiredrelease) Report Ocean Pvt Ltd –:The Global Blood Cancer Drugs Market is estimated to see healthy growth, pegged at a CAGR of around 6% throughout the forecast period 2020-2025.
The increasing prevalence of blood cancer cases and the growing death incidence rate worldwide are the main blood cancer drug market drivers. Also, the different blood cancers types such as lymphoma, myeloma, leukemia, and others have various risk factors that can be prevented or controlled through drug therapies, and others may lead to death. According to the 2018 Bristol-Myers Squibb Company report, over 1.85 million new blood cancer cases are expected to be diagnosed globally in 2040, out of which 918,872 cases are from lymph, 656,345 from leukemia, a